KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Invested Capital (2016 - 2025)

AbbVie (ABBV) has disclosed Return on Invested Capital for 13 consecutive years, with 0.32% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital rose 5.0% to 0.32% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.32% through Dec 2025, up 5.0% year-over-year, with the annual reading at 0.15% for FY2025, 0.0% changed from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.32% at AbbVie, down from 21.7% in the prior quarter.
  • The five-year high for Return on Invested Capital was 21.7% in Q3 2025, with the low at 0.21% in Q4 2023.
  • Average Return on Invested Capital over 5 years is 1.84%, with a median of 0.41% recorded in 2024.
  • The sharpest move saw Return on Invested Capital tumbled -127bps in 2021, then soared 2099bps in 2025.
  • Over 5 years, Return on Invested Capital stood at 0.3% in 2021, then grew by 1bps to 0.3% in 2022, then dropped by -29bps to 0.21% in 2023, then grew by 26bps to 0.27% in 2024, then rose by 18bps to 0.32% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.32%, 21.7%, and 5.55% for Q4 2025, Q3 2025, and Q2 2025 respectively.